HeraMED Limited develops and sells pregnancy monitoring solutions for home and professional use in Australia, Europe, and Israel. The company's product is the HeraBEAT, a fetal heart rate monitor principally for use by an expectant mother to monitor their fetus' heartbeat. It is also involved in developing EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has co-development agreement with Mayo Clinic for developing platform for pregnancy homecare; and cooperation agreement with Freeman Rd & PHI Group to arrange and lead clinical studies in Australia HeraMED Limited was founded in 2011 and is based in Sydney, Australia.